Clinical Trial Update: Real World Use of Tocilizumab Biosimilar studY

View source ↗

Summary

An observational update on real-world use of a tocilizumab biosimilar for rheumatoid arthritis, with the study currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tocilizumab biosimilar (tocilizumab)

Snippet

Sponsor: Fresenius Kabi SwissBioSim GmbH | Conditions: Rheumatoid Arthritis | Status: ACTIVE_NOT_RECRUITING